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Abstract
Analyses of viral protein-protein interactions are an important step to understand viral protein functions and their
underlying molecular mechanisms. In this study, we adopted a mammalian two-hybrid system to screen the genome-wide
intraviral protein-protein interactions of SARS coronavirus (SARS-CoV) and therefrom revealed a number of novel
interactions which could be partly confirmed by in vitro biochemical assays. Three pairs of the interactions identified were
detected in both directions: non-structural protein (nsp) 10 and nsp14, nsp10 and nsp16, and nsp7 and nsp8. The
interactions between the multifunctional nsp10 and nsp14 or nsp16, which are the unique proteins found in the members
of Nidovirales with large RNA genomes including coronaviruses and toroviruses, may have important implication for the
mechanisms of replication/transcription complex assembly and functions of these viruses. Using a SARS-CoV replicon
expressing a luciferase reporter under the control of a transcription regulating sequence, it has been shown that several
viral proteins (N, X and SUD domains of nsp3, and nsp12) provided in trans stimulated the replicon reporter activity,
indicating that these proteins may regulate coronavirus replication and transcription. Collectively, our findings provide a
basis and platform for further characterization of the functions and mechanisms of coronavirus proteins.
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Introduction
Interactions between viral proteins play pivotal roles in many
processes during the viral infection cycle. This is the case in the
formation of virus replication complexes, coordinated functions
between different viral proteins, assembly of virions, and counter-
defense of host immune responses. Analysis of protein-protein
interactions is essential to understand protein functions and the
molecular mechanisms underlying biological processes. As the
viral genomes are of limited sizes, they are particularly well suited
for genome-wide analysis of all possible protein-protein interac-
tions. However, the viral protein interaction maps have been
generated until now only for a limited number of viruses, including
T7 bacteriophage [1], vaccinia virus [2], potato virus A [3], pea
seed-borne mosaic virus [3], wheat steak mosaic virus [4], hepatitis
C virus [5,6], porcine teschovirus [7], Kaposi sarcoma-associated
herpesvirus [8], and very recently severe acute respiratory
syndrome coronavirus (SARS-CoV) [9,10].
Although a large variety of methods have been developed to detect
protein-protein interactions, only a few of them are suited for large-
scale and high throughput protein interaction analysis. Until now, all
the genome-wide analysis of protein interaction networks for viruses
and cells have been carried out mainly with the yeast two-hybrid
systems, in combination with glutathione-S-transferase (GST) pull-
down assays to verify major interactions [8,9]. Considering that
protein modifications that are likely to influence protein interactions
may be different for certain proteins in the context of yeast and
mammalian cells, the mammalian two-hybrid system may better
reflect genuine protein interactions for human viruses. Accordingly,
we adopted the mammalian two-hybridsystem for detecting genome-
wide protein-protein interactions of SARS-CoV.
The coronaviruses are classified into the family Coronaviridae in the
order Nidovirales and possess the largest RNA genomes known. The
genomeof SARS-CoV contains a single-stranded, plus-sense RNA of
approximately 29.7 kb in length. Fourteen open reading frames
(ORFs) have been identified, of which 12 are located in the 39 end of
the genome [11,12]. The two large ORFs (1a and 1b) in the 59-
proximal two-third of the genome encode the viral replicase and are
translated directly from the genomic RNA, while ORF 1b is
expressed by 21 ribosomal frameshifting. The large polypeptides
encoded by 1a and 1b are considered to be cleaved into 16 functional
replicase proteins by two proteinases, a papain-like proteinase 2
encoded by nsp3 and a 3C-like proteinase (or main proteinase)
encoded by nsp5 [12].
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for the 16 non-structural proteins (nsps). Nsp1 was proved to be
able to suppress host gene expression by promoting host mRNA
degradation and was involved in cellular chemokine deregula-
tion [13,14]. Nsp2 seems not to play a crucial role in the
generation of infectious viruses in cell culture [15]. Nsp3 is
involved in many activities including papain-like proteinase
activity, deubiquitinating activity, and ADP-ribose-10-phospha-
tase activity [16–18,60], which are essential for viral replication
and transcription. Nsp5 encodes a 3C-like proteinase which is
considered to be an important target for antiviral drug design
[19]. Coronavirus nsp4 and nsp6 are transmembrane proteins
that could anchor the replication complexes to double
membrane vesicles [20]. Based on the structural analysis,
hexadecamer of nsp7 and nsp8 may possess dsRNA-binding
activity [21]. Nsp8 was shown to have RNA-dependent RNA
polymerase (RdRp) activity that could be involved in producing
primers utilized by nsp12 which is normally accepted to be the
RdRp for SARS-CoV [22,23]. Nsp9 is a single-stranded RNA-
binding protein [24]. Though the structure of nsp10 is resolved,
its function is still poorly understood, except that of nsp10 of
MHV, homologous to that of SARS-CoV, which regulates viral
RNA synthesis [25–27]. Nsp13 is shown to be RNA helicase
and 59-triphosphatase that may play a crucial role in the viral
RNA capping [28,29]. Nsp14 of coronaviruses possesses a 39-
.59 exoribonuclease activity which may be involved in the
proof-reading ability during the viral RNA replication and
transcription [30–32]. Besides the exoribonuclease activity,
SARS-CoV also possesses the endoribonuclease activity that is
rendered by nsp15 [33]. According to the bioinformatic
prediction, nsp16 and SUD domain of nsp3 of SARS-CoV
may function as 29-O methyltransferase and guanine N7
methyltransferase, respectively [34,35]. Very recently, the 29-O
methyltransferase activity was confirmed experimentally for
nsp16 of feline coronavirus [36]. Nsp14, 15 and 16 were
shown to be essential for efficient replication of coronavirus
[30,37,38].
The 39 one-third of genome encodes 12 viral proteins including
the structural and accessory proteins, which are translated from
about 10 subgenomic RNAs [39,40]. Proteins S, E, M, and N are
four well described structural proteins, and 3a, 6, 7a, and 7b were
also reported to be virion-associated proteins or viral structural
proteins [41–44]. Multiple functions and activities have been
identified for the structural and accessory proteins, including
apoptosis induction, interference with the innate immunity
response, and regulating the cellular protein expression [45].
However, these proteins are not essential for viral replication and
transcription at least in cell culture and tested animal models,
except nucleocapsid (N) protein [46–49].
Previous studies on SARS-CoV focused mostly on the
molecular characterization and functional analysis of individual
proteins encoded by SARS-CoV and limited information is
available on viral protein-protein networks of coronaviruses [50].
To provide more insights into the functions of individual proteins,
we analyzed interactions between all SARS-CoV-encoded pro-
teins. By using mammalian two-hybrid assays, 40 different
interactions between viral proteins have been identified, and six
novel interactions could be confirmed in vitro by biochemical
assays. Moreover, a sensitive replication and transcription reporter
system of SARS-CoV was established in this study, and, based on
this system, we examined the impacts of all the individual viral
proteins on the viral replication and transcription and found that
the N protein played an important role at the early stage of SARS-
CoV genome replication.
Results
Identification of protein-protein interactions of SARS-CoV
based on mammalian two-hybrid assays
In this study, a mammalian two-hybrid system was adopted to
analyze the protein-protein interactions of SARS-CoV as it was
assumed that the viral proteins expressed in mammalian cells were
prone to be in their native conformations and therefore the
interactions detected were more likely to be biologically relevant in
comparison with other in vitro biochemical methods and assays
performed in yeast cells [51].
For analysis of genome-wide protein interactions of SARS-CoV,
all known ORFs were amplified by PCR from viral cDNAs of
SARS-CoV isolate WHU [39] and cloned into pGEM-T vector
(Table 1). The large polyprotein encoded by ORF 1a/b was split
into 18 domains according to the proteinase cleavage sites, except
for nsp3 which was divided into 3 parts based on predicted
functional domains. For structural and accessory proteins, the
intact ORFs including start and stop codons were amplified,
except for S protein which was divided into S1 and S2 as these
domains were proved to be two separate domains with distinct
functions [52]. All the primers used for amplification were
designed by inserting appropriate restriction sites which could be
used for subcloning all the fragments from pGEM-T cloning
vectors into mammalian two-hybrid vectors pM (bait) and pVP16
(prey) and other protein expression vectors (see below) in correct
reading frames.
In total, 1024 interaction combinations between all SARS-CoV
proteins were examined in a pairwise matrix. As a result, 40
different interactions were detected using the mammalian two-
hybrid assays (Fig. 1A). All the interactions shown (Fig. 1) were
most likely specific for the viral protein domain of the fusion
proteins as the activities of the reporter genes were reduced to
background levels when one interacting partner in any of the
combinations was replaced with non-relevant fusion protein
(negative control) (data not shown). To further show the specificity
of the interactions (Fig. 1), a quantitative assay for a typical positive
interaction exemplified by nsp10–nsp14 and various controls were
shown (Fig. 1B). To test the specificity of individual interactions,
competitive assays were performed by co-expression of viral
proteins using a different vector within the cells transformed with
the bait and prey constructs. The co-expressed partner proteins
interfered with the nsp10–nsp14 interaction, leading to reduced
reporter activity (Fig. 1C), indicating that the same proteins with
different fusion domains competed with each other and impaired
the specific interactions needed for activation of the reporter
genes.
Most interactions showed directionality, indicating the influence
of fusion domains on the interacting sites. Nevertheless, three pairs
of interactions were detected in both directions: nsp10 and nsp14,
nsp10 and nsp16, and nsp7 and nsp8. Nsp11 is a small polypeptide
containing only 13 amino acids and no interaction was detected
with it in various assays but nsp11 in the fusion with nsp10 (nsp10/
11) could significantly enhance the binding capability of nsp10
with either nsp14 or nsp16, indicating that the small nsp11 may
also play important roles in viral protein interactions and
replication. Self-interactions of nsp3, nsp5, nsp8, nsp15 and N
were observed, suggesting that these proteins could form dimeric
or multimeric complexes by interacting with themselves. Further-
more, 8 interactions between non-structural proteins and acces-
sory proteins (3b, 7b, 8b, 9b) and one interaction between non-
structural protein nsp16 and structural protein N were detected,
indicating that some of the accessory proteins might be involved in
viral replication and transcription processes. Nevertheless, that
SARS-CoV Protein Interactions
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modulating virus replication as the virus-specific proteins are not
strictly essential for viral replication at least in cell culture and
mouse models [48,49].
Confirmation of SARS-CoV protein interactions by pull-
down assays
To confirm the interactions which were newly detected by
mammalian two-hybrid assays, pull-down assays were performed.
Proteins that were related to the interactions not reported
previously were expressed in different bacterial systems including
pET30a (His-tagged), pGEX-6P-1 (GST fusion) and pMAL-c2X
(MBP fusion). Using pull-down assays that were described in
Materials and Methods section, six protein-protein interactions
were confirmed, including those between: nsp10 and nsp14, nsp10
and nsp16, nsp13 and 3b, nsp8 and 3b, nsp16 and N, and 8b and
N (Fig. 2). Due to difficulties in bacteria expression, the
interactions involving nsp12, nsp3.2 and nsp3.3 could not be
confirmed.
Establishment of a reporter gene-containing replicon and
analysis of the impacts of viral proteins provided in trans
on viral replication/transcription of SARS-CoV
Although a large number of protein-protein interactions were
detected for SARS-CoV in virtue of the large-scale screening
analysis in mammalian two-hybrid system, the roles of these
interactions in the viral replication and transcription were still not
clarified. To obtain more clues to the general roles of individual
proteins, we constructed a SARS-CoV replicon (Rep-SCV-luc/
neo) that expresses the firefly luciferase gene, a sensitive reporter,
Table 1. The sequences of SARS-CoV used for interaction analysis.
Protein Coding sequence* Position in polyprotein* Protein length Function described**
nsp1 265–804 M1-180G 180 Regulation of host gene expression
nsp2 805–2718 A181-G818 638
nsp3.1 2719–4896 A819-T1544 726 ADRP, SUD for OGB
nsp3.2 4897–7035 I1545-D2257 713 PLpro, DU
nsp3.3 7036–8484 F2258-G2740 483
nsp4 8485–9984 K2741- Q3240 500 TM
nsp5 9985–10902 S3241- Q3546 306 3CLpro
nsp6 10903–11772 G3547- Q3836 290 TM
nsp7 11773–12021 S3837-Q3919 83 dsRNA-binding
nsp8 12022–12615 A3920-Q4117 198 dsRNA-binding & RdRp
nsp9 12616–12954 N4118-Q4230 113 ssRNA-binding
nsp10 12955–13371 A4231-Q4369 139 Regulation of viral RNA synthesis
nsp10–11 12955–13410 A4231-Q4382 152
nsp11 13372–13410 S4370-V4382 13
nsp12 13372–16166 S4370-Q5301 932 RdRp
nsp13 16167–17969 A5302-Q5902 601 Hel, NTPase
nsp14 17970–19550 A5903-Q6429 527 ExoN
nsp15 19551–20588 S6430-Q6775 346 XendoU
nsp16 20589–21482 A6776-N7073 298 29-O-MT
S1 21492–23531 n/a 680 spike (receptor-binding)
S2 23532–25259 n/a 575 spike (fusion peptide,& TM)
3a 25268–26092 n/a 274 TM, ion channel
3b 25689–26153 n/a 154 TM, antagonist of IFN
E 26117–26347 n/a 76 envelope
M 26398–27063 n/a 221 membrane
6 27074–27265 n/a 63 antagonist of IFN
7a 27273–27641 n/a 122
7b 27638–27772 n/a 44
8b 27864–28118 n/a 39
N 28120–29388 n/a 422 Nucleocapsid, antagonist of IFN
9b 28130–28426 n/a 98
*The coordinate of the sequence is based on the genome of SARS-CoV WHU (GenBank accession number: AY394850). n/a: not applied.
**Abbreviations: ADRP, adenosine diphosphate-ribose 10-phosphatase; SUD, SARS Unique Domain; OGB, oligo(G)-binding; PLpro, papain-like cysteine proteinase; DU,
deubiquitinating activity; TM, transmembrane domain; 3CLpro, 3C-like cysteine proteinase; RdRp, RNA-dependent RNA polymerase; Hel, 59 to 39 RNA helicase; NTPase,
NTP and RNA 59 triphosphatase; ExoN, 39 to 59 exonuclease; XendoU, endoribonuclease; 29-O-MT, S-adenosylmethionine-dependent ribose 29-O-methyltransferase;
IFN, interferon.
doi:10.1371/journal.pone.0003299.t001
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PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3299Figure 1. Protein interactions of SARS-CoV detected by mammalian two-hybrid assays. (A) Interaction matrix of SARS-CoV proteins. The
grey squares indicate the novel interactions detected in this work. The black squares represent the interactions which have also been reported
previously, including nsp5–nsp5[19,68,69], nsp5–nsp7 and nsp8[9], nsp7–nsp7[21,70], nsp7–nsp8[21], nsp7–nsp9[9], nsp8–9b[9], nsp10–nsp14 and
nsp10–nsp16[10], nsp15–nsp15 [54,56,71,72], nsp7-E and 7a-M[73], N-N[55,57] and N-N[55,57]. (B) A typical result for a positive interaction with the
example of nsp10–nsp14. The combination of pM-53 and pVP16-T represents a positive control. (C) A typical interaction inhibition assay performed to
confirm that the interaction was not resulted from self-activation. Error bars represent standard deviations from three independent experiments.
doi:10.1371/journal.pone.0003299.g001
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(TRS) as described in the Materials and Methods section (Fig. 3A).
The effects of individual proteins or protein domains provided in
trans on the replication/transcription of the SARS-CoV replicon
were evaluated. Any effect of the protein provided in trans on the
luciferase expression levels could in principle be due either to
changes in the extent of the replication, the transcription, or a
combination of both.
To evaluate the reporter gene expression of the replicon
generated in this work, the BAC plasmid encoding Rep-neo/luc
(pBAC-Rep-SCV-neo/luc) was transfected into BHK21 cells. A
significant increase in luciferase activity, in comparison with that of
the parental replicon plasmid pBAC-SARS-CoV-REP was ob-
served (Fig. 3B). As the luciferase gene is located in the 39-end of the
genome and under the control of a viral TRS, it can only be
expressed from subgenomic RNAs but not from the viral genome
RNA. Therefore, expression of luciferase was expected to reflect the
genome replication and transcription of SARS-CoV replicon. To
further clarify whether the luciferase expression of Rep-SCV-luc/
neo derived from the viral replication and transcription processes
but not from nuclear splicing products of the large viral replicon
RNA during the CMV promoter-driven transcription in nucleus,
the positive and negative subgenomic RNAs were examined
according to the strategy described in our previous work [39] and
the existence of correct subgenomic RNAs was confirmed (data no
shown). Moreover, when the gene segment between two MluI
restriction sites in viral genome, which encodes nsp4–nsp11 and
part of nsp12, was deleted, the construct pBAC-Rep-SCV-DMlu-
luc/neo produced much lower levels of luciferase expression
although it still retained detectable level of luciferase activity
(Fig. 3B). To analyze the luciferase expression from the MluI
deletion mutant, the identity of the luciferase mRNA was
sequenced. The results showed that a low level of luciferase mRNA
was generated either by cryptic promoters or by splicing of cryptic
introns within the replicon transcripts in nucleus but not in the
mRNAs derived from the cytoplasmic replication and transcription
of the replicon (data not shown). Taken together, these results
showed that the reporter-containing SARS-CoV replicon could be
used as a model system for analyzing the functions of viral proteins.
To study the effect of SARS-CoV proteins on replication and
transcription, individual viral proteins were co-expressed in trans with
the SARS-CoV replicon. Renilla luciferase was employed as an
internal control reporter to normalize the transfections among
different wells (Fig. 4). Though most of the viral proteins did not exert
significant impact on the replication and transcription of the replicon,
the nsp3.1 containing X and SUD domains, and the RNA
polymerase nsp12 (Fig. 4A),and nucleocapsid N (Fig. 4B) significantly
increased the luciferase activity, whereas nsp3.2 containing the
papain-like (PL) proteinase domain reduced the viral replication and
transcription. Other proteins, such as nsp10/11, also showed a minor
but significant increased expression. These results confirmed that the
function of N gene fragment was not resulted from protein 9b that is
internally nested in N sequence, as 9b showed no obvious impact on
the replication and transcription of replicon when it was co-expressed
(Fig. 4B). In addition, these results indicate that nucleocapsid protein,
nsp3 and RNA polymerase may possess a dominant function in trans,
while the PL proteinase is involved in important cis functions like cis-
processing of the large viral polyprotein.
Trans-activation activity of N protein at the early stage of
genome replication or transcription of SARS-CoV
To make further analysis on the enhancement effect of N
protein on the viral replication and transcription, we examined the
dynamic changes of the luciferase activity expressed from the
reporter replicon Rep-SCV-luc/neo. When the replicon plasmid
pBAC-Rep-SCV-luc/neo was transfected alone, the luciferase
Figure 2. Confirmation of the novel interactions by pull-down assays. The two test proteins were fused with glutathione S-transferase (GST)
and maltose-binding protein (MBP), respectively, and mixed for binding in PBS buffer as described in the Materials and Methods section. The protein
mixture was pulled down with glutathione-Sepharose that binds GST and GST fusion proteins. Proteins bound by glutathione-Sepharose were
resolved in SDS-PAGE, transferred to PVDF membrane and then was detected by anti-MBP rabbit serum. For every assay, GST protein was used as a
negative control. For example, to examine the interaction between nsp10 and nsp14, the mixtures of GST-nsp10/MBP-nsp14 and GST/MBP-nsp14
were incubated with glutathione-Sepharose and the proteins pulled down by glutathione-Sepharose were identified by anti-MBP rabbit serum,
respectively. The proteins indicated on the left side of the vertical line were MBP fusions and that on the right are GST fusions with ‘‘-’’ indicating non-
fused GST as negative control. The star signs indicate the expected bands for MBP-fusion proteins. The smaller bands observed are probably
premature proteins or degradation products of the same proteins.
doi:10.1371/journal.pone.0003299.g002
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times compared with background levels) while the highest value of
activity was reached around 32 h post transfection (Fig. 5A). The
luciferase activity became stable 72 h post transfection and the
activity level was as low as that of 14 h post transfection (Fig. 5A).
To study the role of N protein provided in trans, we next
transfected cells with equal amount of the reporter replicon
together with either N protein expression construct (pcDNA3.0-N)
or the empty vector pcDNA3.0. Luciferase activity became
detectable at 7 h post transfection when N protein was provided
in trans (Fig. 5B), which was 9 h earlier than similar transfection
without additional N protein (Fig. 5B). It was also observed that
the luciferase activity was significantly enhanced in the first 40 h
post transfection (Fig. 5B). The ratios of luciferase activities with
and without co-expression of N protein at different time points
post transfection were shown in Fig. 5C. The ratios became lower
step by step from over 50 times at 16 h post transfection to around
4 times at 38 h post transfection (Fig. 5C). The corresponding
ratios for nsp3.2, nsp3.1 and nsp12 were also investigated and no
similar phenomena were observed (data not shown). Collectively,
these data showed that the nucleocapsid N protein provided in
trans could enhance the efficiency of SARS-CoV genome
replication and transcription at early stages.
Discussion
Coronaviruses have the largest RNA genome known, which
encodes a large number of proteins that are involved in viral
replication, assembly, and other important functions that are
essential to viral amplification in host cells. Except for some viral
proteins that might perform their activities individually, most of
the viral proteins could associate with other proteins or themselves
to carry out their functions, indicating that the interactions
between these proteins may play a crucial role during the viral life
cycle. For SARS-CoV, at least 17 proteins, including 16 non-
structural proteins and the structural nucleocapsid protein, are
most likely involved in the replication process [12,53].
In this study, a mammalian two-hybrid system was used to
determine the genome-wide matrix-based protein-protein interac-
tions of SARS-CoV. In total, 40 different interactions for 28
predicted mature proteins were observed, and most of them have
not been previously reported. Interestingly, 32 percent of the
interactions tested could be confirmed by pull down assays. To our
knowledge, this is the first genome-wide protein-protein analyses
Figure 3. Structure and activity assay of the reporter replicon
construct pBAC-Rep-SCV-luc/neo. (A) Schematic structure of the
replicon. The coding sequence of luciferase-neomycin fusion under the
control of M gene TRS was inserted into the basic replicon construct
pBAC-SARS-CoV-REP between AscI and BamHI sites (For details, see the
Materials and Methods). (B) Luciferase assays of the reporter replicons.
2610
5 BHK21 cells were transfected with the three kinds of replicon
plasmids (0.4 mg each), respectively, and pRL-TK plasmid (0.1 mg) as an
internal control. The luciferase activity assays were performed 24 h post
transfection. Error bars represent standard deviations of the mean of
three experiments.
doi:10.1371/journal.pone.0003299.g003
Figure 4. Impacts of viral proteins provided in trans on the
replication/ transcription of SARS-CoV replicon. (A) Nonstructur-
al proteins; (B) Structural and accessory proteins. 2610
5 BHK21 cells
were transfected with pBAC- Rep-SCV-luc/neo (0.25 mg), the viral
protein expression plasmids (0.2 mg each) and pRL-TK (0.05 mg) as an
internal control. The corresponding empty vectors (0.2 mg each) were
used as the negative controls. The luciferase activities were measured
24 h post transfection. Error bars represent standard deviations of the
mean of three experiments.
doi:10.1371/journal.pone.0003299.g004
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system. In our screen, 1.4 protein interactions per viral protein on
the average was detected, and this result is in the upper range of
the detection rates of viral protein interactions obtained by yeast
two-hybrid systems [58]. Therefore, this study indicates that
mammalian two-hybrid system can also serve as a convenient
system to detect viral protein interactions of the whole ORFeomes.
In addition, mammalian two-hybrid system may have some
advantages over yeast two-hybrid system for detecting genuine
viral protein interactions due to the native posttranslational
modifications and folding of the proteins.
Very recently, two large-scale analyses of protein interactions of
SARS-CoV were carried out by using yeast two-hybrid systems
[9,10]. In the report by von Brunn et al, 70 pairs of interactions
were revealed, among which 30% could be verified by co-
immunoprecipitation [9]. In the work by Imbert et al, 17 pairs of
interactions were observed for non-structural proteins, about half
of which were related to nsp3 [10]. Surprisingly, none of the
interactions revealed in the two studies was overlapping although
they both employed the yeast two-hybrid system for the screening.
In contrast, overlapping interactions could be identified between
that detected by mammalian two-hybrid system in current work
and that by different yeast two-hybrid systems. There are 9 pairs of
interactions found in our work that are overlapping with that of
von Brunn et al, and they are nsp5 with nsp5, nsp7 and nsp8, nsp7
with nsp7, nsp8 and nsp9, nsp8 with nsp8, nsp9 and 9b. There are
4 pairs of interactions found in this study that are identical to that
of Imbert et al. and they are nsp10 with nsp14 and nsp16 in both
directions. Interestingly, all the overlapping interactions repre-
sented strong interactions in the mammalian two-hybrid assays
and could be verified by biochemical assays.
In the two previous studies with yeast two-hybrid system, four
proteins (nsp2, nsp3, nsp8 and 9b) were shown to have a wide
range of interactions with other viral proteins, but these
phenomena could not be observed in mammalian two-hybrid
assays. In contrast, a number of interactions including N-N and
nsp15–nsp15 were detected in current study and proved previously
by other studies [54–57] but they could not be revealed by the
yeast two-hybrid systems [9,10]. Intriguingly, the two strong
interactions nsp10–nsp14 and nsp10–nsp16 identified in mamma-
lian two-hybrid system was also revealed in a yeast two-hybrid
system by Imbert et al. [10] but not by von Brunn et al [9].
Although it is difficult to judge which system offers more
biologically relevant results, great caution should be taken when
interpreting the interaction data as both two-hybrid screenings as
well as biochemical methods may generate false positive and false
negative interactions. Nevertheless, the above comparative
analysis of overlapping interactions of different systems may
suggest that mammalian two-hybrid system could provide more
reliable assays for detecting human viral protein interactions. In
other scenario, the profiles of SARS-CoV protein interactions
revealed by mammalian two-hybrid system (in this work) and yeast
systems [9,10], respectively, may be complementary to each other
and jointly serve as a framework for further characterization of
protein-protein interactions and their biological functions on
coronavirus replication cycle.
Similar to that of yeast two-hybrid system, the detectable
protein interactions all take place in the nucleus whereas, on the
Figure 5. The effect of additional N protein on viral genome
replication and transcription. (A) Kinetics of luciferase activity of the
reporter replicon. 2610
5 BHK21 cells were transfected with pRL-TK
plasmid (0.1 mg) and pBAC-Rep-SCV-luc/neo (0.4 mg). After transfection,
the cells were collected for luciferase assays at different time points (6 h
to 72 h). (B) Reporter gene activity in presence or absence of additional
N protein provided in trans.2 610
5 BHK21 cells were transfected with
pRL-TK plasmid (0.05 mg), pBAC-Rep-SCV-luc/neo (0.25 mg) and
pcDNA3.0-N (0.2 mg) or pcDNA3.0 (0.2 mg). After transfection, the cells
were harvested for luciferase assays at different time points (6 h to
38 h). (C) The ratios of luciferase activities of Rep-SCV-luc/neo in
presence of N protein related to that in absence of N protein at
different time points (6 h to 38 h). Error bars represent standard
deviations of the mean of three experiments.
doi:10.1371/journal.pone.0003299.g005
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the natural location for viral proteins. Thus, the two-hybrid
systems may have obvious limitation on detecting proteins that
contain transmembrane domains or change to abnormal confor-
mations in acidic conditions, and this may represent one reason for
generating false negative and false positive interactions. In current
screen, only few interactions were detected for the SARS-CoV
membrane proteins such as nsp4, M, E and 3a proteins, and no
interactions could be detected for nsp1, nsp6, spike and the small
transmembrane protein 6, possibly reflecting the limitation of the
two-hybrid system. Therefore, using shorter or random cDNA
fragments by removing the transmembrane and other inhibitory
domains may help detect more interactions in this system.
In this study, we have detected several interactions between
accessory proteins and replicase proteins, for example, 3b with
nsp8, nsp12, nsp13 or nsp14, 7b with nsp9 or nsp16, 8b with nsp9,
and 9b with nsp8. Interestingly, among these interactions those
between 3b with nsp8 and nsp13 were confirmed by pull-down
assays. However, previous studies showed that deletions of ORFs
3b, 7b, 8b and 9b alone or in combination with other virus-specific
proteins did not significantly influence the level of viral RNA and
replication efficiency in cell culture and mouse models [48,49],
suggesting either that these interactions may not play significant
roles in viral replication or that these systems are not sensitive
enough to detect minor differences. In any case, it would be
reasonable to speculate that such interactions may contribute to
the virus-host interplay and hence to the viral pathogenicity.
The interactions between nsp10 with nsp14 and nsp16 showed
bi-directionality in the mammalian two-hybrid analyses, which
could be confirmed in pull-down assays and were also revealed in
one of the two yeast-hybrid analyses [10]. Recently, nsp10 was
shown to form a dodecameric RNA-binding protein complex
[26,27] involved in regulation of RNA synthesis and polyprotein
processing [25,59]. Nsp14 and nsp16 were proved to play an
essential role in viral replication and transcription as shown by
mutational analysis [37]. Considering that nsp14 has exoribonu-
clease activity and could play an essential role in RNA proof-
reading activity [30–32], and that nsp16 is involved in the viral
methyltransferase activity and RNA capping [34,36], the interac-
tions of nsp10 with nsp14 and nsp16 may indicate that nsp10
could play an important role in the formation of replication
complex bound to RNA (i.e., nsp10 could mediate the binding of
nsp14 and nsp16 to the RNA) and in the replication/transcription
processes. Although no interactions were detected for nsp11,
which was predicted to be small polypeptide with 13 amino acids,
fusion of nsp11 with nsp10 strengthened the respective interactions
of nsp10 with nsp14 and nsp16. These observations may imply
that nsp11 could act as a cofactor for nsp10 and the predicted
cleavage site between nsp10 and nsp11 may be inefficient in vivo,
thus resulting in the production of nsp10/nsp11 fusion protein in
cells. Indeed, no evidence for existence of the fully processed nsp11
has been presented in published researches. However, such
speculation needs to be confirmed by further investigations.
Several interactions detected in current work have also been
observed in previous studies. For example, nsp7 and nsp8 could
associate with each other and thus form a hexadecameric super-
complex with a central channel that has dimensions and positive
electrostatic properties favorable for nucleic acid binding [21].
Consistent with our results, self-interactions of N protein and nsp15
have also been revealed and the results indicate that these proteins
have the propensity to oligomerize [56,57,61]. In this study, a
SARS-CoV replicon containing a sensitive luciferase reporter was
constructed, with its expression under the control of M gene TRS.
In this situation, the reporter activity would indicate the efficiency of
both genome replication and transcription. When individual viral
proteins were provided in trans to the reporter replicon, most
proteins did not exert significant influence on the reporter activity,
with exception of nsp3, nsp12 (polymerase), and nucleocapsid
protein N. As protein nsp3 is a large multidomain protein, different
domains were tested separately in this system. While nsp3.1 that
covers domains predicted for adenosine diphosphate-ribose 10-
phosphatase [12] and methyltransferase [35] could enhance the
reporter activity, the nsp3.2 had a negative effect, indicating the
domains in nsp3.2 may play structural roles in the formation of
replication/transcription complex and could behave in a dominant-
negative manner when separated from other domains. In
accordance with this hypothesis, nsp3.2 was found to associate
with itself, nsp4 and nsp12 in this work.
N protein of coronaviruses increases the rescue efficiency of
coronaviruses from infectious RNA transcripts [37,49,62] and is
required for efficient genome replication [53,63]. In this study, we
showed that N protein was not absolutely essential for starting the
replication but may play important roles at the early stages of
genome replication and/or transcription because the reporter
replicon in absence of additional N protein provided in trans also
resulted in obvious replication and transcription but in lower
efficiency and delayed manner. The enhancement effects of N
protein phased out at late stage probably when the N protein
expressed from the genome had accumulated to certain level.
Although the exact mechanisms for N-mediated stimulation
activity at early stages are not known, several scenarios could be
envisaged, such as protecting viral genome RNA, increasing the
translation efficiency of viral RNA, stabilizing replication/
transcription protein complex and inhibition of cellular innate
immune responses, as is supported by the recent reports on
diversified functions of N protein [64,65].
In summary, current work constructed an interaction network
of SARS-CoV proteins and established a sensitive replicon for
studying the functions of individual viral proteins. The intraviral
protein interactions identified in this study, in combination with
the data obtained by using other systems, could serve as a basis for
further studies of viral protein functions and molecular mecha-
nisms of the genome replication/transcription processes of
coronaviruses.
Materials and Methods
Cells and viral cDNAs
African green monkey kidney (Vero E6) cells, baby hamster
kidney (BHK21) cells and 293T cells were grown and maintained
in Dulbecco’s modified Eagle medium and modified Eagle
medium (Gibco Invitrogen), respectively, supplemented with
10% heat-inactivated fetal bovine serum and 100 U/ml of
penicillin and 100 mg/ml of streptomycin (Gibco Invitrogen).
Viral cDNAs encoding individual SARS-CoV ORFs were
generated and described in our previous work [39,66].
Cloning and expression of the SARS-CoV ORFs
The primers for individual ORFs were designed according to
the genome sequence of SARS coronavirus strain WHU
(GenBank accession number: AY394850) with restriction sites
which were compatible for the downstream subclonings. The
reagents for PCR were 0.2 mM dNTPs, 0.4 mM forward and
reverse primers, ,10 ng template DNA and 1 U of KOD DNA
polymerase (TOYOBO) in 50 ml reaction system. The amplifica-
tion conditions were 94uC for 2 min and 30 cycles of 94uC for
15 sec, 52uC for 15 sec and 68uC for 3 min, followed by 68uC for
10 min and 4uC for 10 min.
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fragments were recovered from the gels by DNA extraction kit
(OMEGA BIO-TECH) and cloned into pGEM-T vector (Pro-
mega) after A-tailing reaction according to standard protocols.
The sequences of positive clones examined by restriction and PCR
analyses were confirmed by DNA sequencing on ABI 3730 DNA
Analyzer (Applied Biosystems) and CEQ
TM 8000 Sequencer
(Beckman Coulter). Subsequently, the coding sequences were cut
from pGEM-T constructs with appropriate restriction enzymes
and cloned into the mammalian two-hybrid vectors pM and
pVP16 (Clontech), Escherichia coli protein expression vectors
pET30a (Novagen), pGEX-6P-1 (Amersham Biosciences) and
pMAL-c2X (New England Biolabs), and mammalian expression
vectors pcDNA3.0 (Invitrogen Corporation), pCMV-Tag2b (Stra-
tagene Corporation) and pCIH that was generated by adding an
ATG-HA-tag oligo at the XhoI-EcoRI sites of vector pCI-Neo
(Promega). Details of the cloning processes and various constructs
can be provided upon request.
Mammalian two-hybrid analysis
The reporter construct pG5-luc was reconstructed from
pG5CAT (Promega) by replacing chloramphenicol acetyl trans-
ferase (CAT) gene with luciferase gene sequence. For protein
interaction analysis, 0.3 mg of DNA-binding domain fusion
constructs in plasmid pM, 0.3 mg of transcriptional activation
domain fusion constructs in plasmid pVP16, 0.15 mg of reporter
construct pG5-luc and 0.1 mg of vector pRL-TK (Promega) as
internal control were transfected into 293T cells by calcium
phosphate transfection method. One day before transfection,
293T cells were seeded in 24-well plate with ,1610
5 cells per
well. On the following day, the DNA of specified amount and
2.5 ml of 2.5 M CaCl2 were diluted with deionized H2O to reach a
final volume of 25 ml. After an incubation for 5 minutes, 25 mlo f
26HBS solution (50 mM HEPES, 10 mM KCl, 12 mM Dex-
trose, 280 mM NaCl, 1.5 mM Na2HPO4, pH 7.05) was added
and mixed. The calcium phosphate-DNA solution was added
dropwise to the cell culture medium while swirling the plate gently.
After incubation for 6 h at 37uC with 5% CO2, the medium was
replaced with fresh one. 24 h later, the luciferase assays were
performed by Dual-Luciferase reporter Assay System (Promega
Corporation) according to the provider’s instructions. Several
control constructs were adopted in the analysis, including pM-53
which encodes the p53 protein, pVP16-T which encodes the SV40
large T antigen, and the empty vectors pM and pVP16. The
known interaction between p53 and T antigen was used as positive
control, and the combinations of test construct and one control
plasmid were assigned as negative controls. The assays on each
pair of plasmid combinations were repeated at least 4 times and 3
wells were examined per assay.
GST-pull down assays
Recombinant glutathione S-transferase (GST)-fusion proteins
and maltose-binding protein (MBP)-fusion proteins were expressed
in E. coli BL21 and DH5a, respectively. Bacterial cells harvested
were resuspended in phosphate-buffered saline (PBS, 10 mM
sodium phosphate, 150 mM NaCl, pH 7.5) and lysed by
sonication in ice. The lysate was subsequently clarified by
centrifugation at 12,000 g for 30 min at 4uC. GST fusion proteins
and GST protein immobilized on glutathione-Sepharose were
coated firstly with MBP protein and were subsequently incubated
with the lysate for MBP-fusion proteins in PBS containing protease
inhibitor cocktail. After incubation with rotation for 2 h, the resin
of glutathione-Sepharose was precipitated by brief spin and
washed by PBS at least for 5 times. The resin was re-suspended
in SDS-PAGE loading buffer and heated at 100uC for 5 min. The
samples were separated in 10% SDS-PAGE and transferred to
PVDF membrane following the standard procedures of Western-
blotting. Anti-MBP rabbit serum (New England Biolabs, dilution
1:5000) was used in the immunoblot analysis to identify MBP-
fusion proteins.
Construction of a replication and transcription report
system for SARS-CoV
The reporter system was based on the primary SARS-CoV
replicon (pBAC-SARS-CoV-REP) [37]. To construct a reporter-
containing replicon including a selection gene for mammalian
cells, the luciferase and neomycin fusion gene cassette was
amplified by PCR from a hepatitis C virus replicon provided by
Dr. Ralf Bartenschlager [67]. The luciferase-neomycin gene
sequence was fused with and thus controlled by the transcription
regulation sequence (TRS) of SARS-CoV M gene. The fused
sequence containing TRS/M-luciferase-neomycin cassette was
inserted between AscI and BamHI sites in pBAC-SARS-CoV-
REP, resulting in the reporter replicon construct pBAC-Rep-SCV-
luc/neo. The cloning details can be provided upon request.
Several transfection strategies and reagents were examined for the
transfection of pBAC-Rep-SCV-luc/neo and the relatively higher
transfection efficiency was obtained with FuGENE HD Transfec-
tion Reagent (Roche Applied Science). Several cell lines were also
examined and BHK21 turned out to better support the
replication/transcription of Rep-SCV-luc/neo and produced
consistent results.
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